Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 27, 2020

SELL
$72.92 - $102.01 $829,027 - $1.16 Million
-11,369 Closed
0 $0
Q2 2020

Aug 04, 2020

BUY
$55.75 - $92.75 $21,073 - $35,059
378 Added 3.44%
11,369 $988,000
Q1 2020

Apr 28, 2020

BUY
$37.9 - $104.44 $416,558 - $1.15 Million
10,991 New
10,991 $637,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Scott & Selber, Inc. Portfolio

Follow Scott & Selber, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott & Selber, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scott & Selber, Inc. with notifications on news.